ImmuCell Corporation Related Party Transaction, Purchases from Related Party
ImmuCell Corporation (ICCC) reported Related Party Transaction, Purchases from Related Party of $462.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty · last filed 2025-08-14
- ImmuCell Corporation related party transaction, purchases from related party for the quarter ending 2025-06-30 was $211.49K, a 54.42% increase year-over-year.
- ImmuCell Corporation related party transaction, purchases from related party for the quarter ending 2025-03-31 was $250.51K, a 87.07% increase year-over-year.
- ImmuCell Corporation related party transaction, purchases from related party for the quarter ending 2024-12-31 was $176.79K, a 71.84% increase year-over-year.
- ImmuCell Corporation related party transaction, purchases from related party for the quarter ending 2024-09-30 was $119.45K, a 65.99% increase year-over-year.
- ImmuCell Corporation related party transaction, purchases from related party for fiscal 2024 was $567.11K, a 145.07% increase from fiscal 2023.
- ImmuCell Corporation related party transaction, purchases from related party for fiscal 2023 was $231.41K, a 60.62% decline from fiscal 2022.
- ImmuCell Corporation related party transaction, purchases from related party for fiscal 2022 was $587.68K.
| Period end | Related Party Transaction, Purchases from Related Party 3 month | Related Party Transaction, Purchases from Related Party 6 month | Related Party Transaction, Purchases from Related Party 9 month | Related Party Transaction, Purchases from Related Party 12 month |
|---|---|---|---|---|
| 2025-06-30 | $211.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $462.00K 10-Q · filed 2025-08-14 | $638.79K derived: sum of 3 quarters · filed 2025-08-14 | $758.25K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $250.51K 10-Q · filed 2025-05-14 | $427.31K derived: sum of 2 quarters · filed 2025-05-14 | $546.76K derived: sum of 3 quarters · filed 2025-05-14 | $683.72K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $176.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $296.25K derived: sum of 2 quarters · filed 2025-03-28 | $433.20K derived: sum of 3 quarters · filed 2025-08-14 | $567.11K 10-K · filed 2025-03-28 |
| 2024-09-30 | $119.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $256.41K derived: sum of 2 quarters · filed 2025-08-14 | $390.32K 10-Q · filed 2024-11-13 | $493.21K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $136.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $270.87K 10-Q · filed 2025-08-14 | $373.75K derived: sum of 3 quarters · filed 2025-08-14 | $445.72K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $133.91K 10-Q · filed 2025-05-14 | $236.79K derived: sum of 2 quarters · filed 2025-05-14 | $308.76K derived: sum of 3 quarters · filed 2025-05-14 | $338.03K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $102.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $174.85K derived: sum of 2 quarters · filed 2025-03-28 | $204.12K derived: sum of 3 quarters · filed 2025-03-28 | $231.41K 10-K · filed 2025-03-28 |
| 2023-09-30 | $71.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $101.23K derived: sum of 2 quarters · filed 2024-11-13 | $128.52K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $29.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $56.56K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $27.29K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $587.68K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |